Exercise Dose Response for Improving Insulin Sensitivity

This study is currently recruiting participants.
Verified December 2012 by University of Michigan
Sponsor:
Collaborator:
Information provided by (Responsible Party):
JEFFREY F HOROWITZ, University of Michigan
ClinicalTrials.gov Identifier:
NCT01452035
First received: October 11, 2011
Last updated: December 14, 2012
Last verified: December 2012

October 11, 2011
December 14, 2012
January 2009
June 2013   (final data collection date for primary outcome measure)
Insulin Sensitivity [ Time Frame: 2-3 hours ] [ Designated as safety issue: No ]
A hyperinsulinemic-euglycemic clamp will be used to assess peripheral insulin sensitivity and will be performed using a primed 2h insulin infusion at a rate of 100 mU/m2/min.
Same as current
Complete list of historical versions of study NCT01452035 on ClinicalTrials.gov Archive Site
  • Resting Metabolic Rate [ Time Frame: 40-60 min ] [ Designated as safety issue: No ]
  • Meal Tolerance Test [ Time Frame: 2-3h ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Exercise Dose Response for Improving Insulin Sensitivity
Comparing the Effects Exercise Intensity and Energy Expended During a Single Exercise Session on Insulin Sensitivity and Fatty Acid Partitioning Within Skeletal Muscle the Next Day in Obese Adults.

Many of the beneficial metabolic effects of endurance exercise training are not due to adaptations to weeks, months, or even years of training, but rather much is due to the response to the most recent exercise session(s). Therefore, the investigators contend that lifestyle interventions for obese individuals should be tailored to optimize the metabolic effects of the most recent exercise session(s). But the "dose" of exercise necessary to evoke these beneficial responses is not known, and the mechanisms responsible for these improvements are poorly understood. The findings from these studies will: 1) establish the minimum "dose" of a single exercise session necessary to improve insulin sensitivity the next day in obese adults, 2) characterize the underlying metabolic factors responsible for the improvement in insulin sensitivity, and 3) assess the cumulative metabolic adaptations that occur over days, weeks, and months of a low-intensity/low-volume lifestyle exercise program. Findings from these studies will provide valuable information for the development of lifestyle programs aimed at maximizing the key metabolic health benefits of each exercise session in obese patients.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Obesity
Other: Exercise
single session of exercise
  • Experimental: Exercise
    Intervention: Other: Exercise
  • No Intervention: Sedentary Control
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
18
June 2013
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Body Mass Index [BMI] = 30-45 kg/m2, weight stable (± 5 lbs in the past month), fasting blood glucose concentration must be <125 mg/dl.

Exclusion Criteria:

  • pregnancy, evidence of cardiovascular or metabolic disease, taking medications know to influence metabolism.
Both
18 Years to 45 Years
Yes
Contact: Suzette Howton, RD 734-647-9850 suzetter@med.umich.edu
United States
 
NCT01452035
R01 DK077966 - MX, R01DK077966
No
JEFFREY F HOROWITZ, University of Michigan
University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Principal Investigator: Jeffrey F Horowitz, Ph.D. University of Michigan
University of Michigan
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP